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Three-Dimensional Echocardiography and 2D-3D Speckle-Tracking
Imaging in Chronic Pulmonary Hypertension: Diagnostic Accuracy in
Detecting Hemodynamic Signs of Right Ventricular (RV) Failure
Antonio Vitarelli, MD; Enrico Mangieri, MD; Claudio Terzano, MD; Carlo Gaudio, MD; Felice Salsano, MD; Edoardo Rosato, MD;
Lidia Capotosto, MD; Simona D’Orazio, MD; Alessia Azzano, MD; Giovanni Truscelli, MD; Nino Cocco, MD; Rasul Ashurov, MD
Background-—Our aim was to compare three-dimensional (3D) and 2D and 3D speckle-tracking (2D-STE, 3D-STE) echocardio-
graphic parameters with conventional right ventricular (RV) indexes in patients with chronic pulmonary hypertension (PH), and
investigate whether these techniques could result in better correlation with hemodynamic variables indicative of heart failure.
Methods and Results-—Seventy-three adult patients (mean age, 5313 years; 44% male) with chronic PH of different etiologies
were studied by echocardiography and cardiac catheterization (25 precapillary PH from pulmonary arterial hypertension, 23
obstructive pulmonary heart disease, and 23 postcapillary PH from mitral regurgitation). Thirty healthy subjects (mean age,
5415 years; 43% male) served as controls. Standard 2D measurements (RV–fractional area change–tricuspid annular plane
systolic excursion) and mitral and tricuspid tissue Doppler annular velocities were obtained. RV 3D volumes and global and regional
ejection fraction (3D-RVEF) were determined. RV strains were calculated by 2D-STE and 3D-STE. RV 3D global-free-wall longitudinal
strain (3DGFW-RVLS), 2D global-free-wall longitudinal strain (GFW-RVLS), apical-free-wall longitudinal strain, basal-free-wall
longitudinal strain, and 3D-RVEF were lower in patients with precapillary PH (P<0.0001) and postcapillary PH (P<0.01) compared to
controls. 3DGFW-RVLS (hazard ratio 4.6, 95% CI 2.79 to 8.38, P=0.004) and 3D-RVEF (hazard ratio 5.3, 95% CI 2.85 to 9.89,
P=0.002) were independent predictors of mortality. Receiver operating characteristic curves showed that the thresholds offering
an adequate compromise between sensitivity and specificity for detecting hemodynamic signs of RV failure were 39% for 3D-RVEF
(AUC 0.89), 17% for 3DGFW-RVLS (AUC 0.88), 18% for GFW-RVLS (AUC 0.88), 16% for apical-free-wall longitudinal strain
(AUC 0.85), 16 mm for tricuspid annular plane systolic excursion (AUC 0.67), and 38% for RV-FAC (AUC 0.62).
Conclusions-—In chronic PH, 3D, 2D-STE and 3D-STE parameters indicate global and regional RV dysfunction that is associated
with RV failure hemodynamics better than conventional echo indices. ( J Am Heart Assoc. 2015;4:e001584 doi: 10.1161/
JAHA.114.001584)
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Q uantitative echocardiographic assessment of right ven-tricular (RV) function is becoming of increasing interest
in cardiac diseases that affect the right ventricle, such as
congenital heart disease and acute or chronic pulmonary
hypertension (PH),1,2 but is still challenging due to RV
complex anatomy and structure. Evaluation of RV function is
particularly important in chronic PH since the primary cause
of death is RV failure that is highly associated with RV
parameters such as cardiac index and right atrial (RA)
pressure. Two-dimensional (2D) echocardiographic methods
of analyzing RV performance employ geometric models that
do not represent the irregular RV shape accurately. Real-time
3-dimensional echocardiography (3DE) allows us to measure
RV end-diastolic volume and ejection fraction (3D-RVEF)
irrespective of its shape and more reliably compare it to
2-DE3–5 and evaluate the morphologic and functional remod-
eling of the right ventricle in PH. Tissue Doppler imaging and
2-dimensional speckle-tracking echocardiography (2D-STE)
are new means of evaluation of myocardial wall movements
and deformation, and it has been suggested that the use of
indexes derived from STE can be proposed as an adjunctive
tool in the overall assessment of RV function.6–9 2D-STE
capability is limited by the changes in heart morphology
during the cardiac cycle and the difficulty in tracking speckles
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in different frames because of out-of-plane motion. The newly
developed 3-dimensional speckle-tracking echocardiography
(3D-STE) provides quick and comprehensive quantitative
assessment of ventricular myocardial dynamics and was
applied to the study of the right ventricle in PH.10,11 However,
the hemodynamic value of these new echocardiographic
parameters in the clinical setting of PH and RV failure was not
clearly established. Accordingly, we sought to analyze the use
of 3DE, 2D-STE, and 3D-STE in the assessment of global and
regional RV function in patients with chronic PH to evaluate
whether these parameters could detect hemodynamic signs
of RV failure better than conventional echo indices.
Methods
Population
We enrolled 73 patients with chronic PH, as defined by the
Task Force of the European Society of Cardiology and
American Heart Association.1,2 The etiology of PH is listed
in Table 1. Precapillary or postcapillary PH was diagnosed
according to current guidelines on the basis of the invasive
hemodynamic evaluation.1 Patients with precapillary PH were
patients with mean pulmonary arterial pressure ≥25 mm Hg
and pulmonary capillary wedge pressure ≤15 mm Hg;
patients with postcapillary PH were patients with mean
pulmonary arterial pressure ≥25 mm Hg and pulmonary
capillary wedge pressure >15 mm Hg. Forty-eight patients
had precapillary PH; 25 of them had pulmonary arterial
hypertension (PAH), and 23 had chronic obstructive pulmo-
nary disease (COPD). Of PAH patients, 13 had congenital
heart disease (ostium secundum atrial septal defect 4
patients, VSD 3 patients, PDA 2 patients, residual shunt from
postoperative ostium primum atrial septal defect 2 patients),
and 12 had systemic sclerosis. Congenital PH patients had no
prior surgery that required operative manipulation of the RV.
Twenty-five patients had postcapillary PH from mitral regur-
gitation (MR). Exclusion criteria included cardiomyopathy,
atrial fibrillation, comorbidities, pregnancy, and insufficient
ultrasound image quality (defined as more than 3 myocardial
segments that were not optimally visualized using conven-
tional 2DE). Patients were followed up with mortality data and
assessed at 24 months. The mean follow-up period was
3.6 years (median 2.8 years). Information about symptoms
and functional class (according to the New York Heart
Association) was collected. Thirty healthy age- and sex-
matched adults who had no histories of cardiopulmonary
disease, no known coronary risk factors, and normal electro-
cardiographic and echocardiographic results, were selected
as a control group. The study was approved by the
Institutional Medical Research Committees. Written informed
consent was obtained.
Standard Echocardiography
All patients underwent transthoracic echocardiography with a
commercially available cardiovascular ultrasound system
(Vivid E9; GE, Horten, Norway). Established criteria were used
for measurements of left and right chambers.12 2D and M-
mode left ventricular (LV) dimensions were obtained. Doppler
mitral peak early (E) and late (A) diastolic velocities, and tissue
Doppler imaging mitral valve annulus velocities (MV Sa, Ea, Aa)
were measured on the transthoracic 4-chamber views. MV E/
Ea ratio is a parameter reflecting LV filling pressure
12 and was
determined by measuring velocities of the lateral mitral valve
annulus. RV to LV end-diastolic diameter ratio was calculated
in the apical 4-chamber view. RV end-diastolic area and end-
systolic area were assessed by manual planimetry, and RV
fractional area change (RVFAC) was derived using the formula
RVFAC=[(RVEDareaRVESarea)/RVEDarea]9100 (where
ED=end diastolic and ES=end systolic). Tricuspid annular
plane systolic excursion (TAPSE) was measured using apical
views adjusted to optimize RV structures and to achieve
proper orientation for M-mode measures. Myocardial perfor-
mance index was derived from the analysis of RV function
Doppler parameters. Pulmonary acceleration time (PAT) was
measured as the interval between the onset of ejection and
peak pulmonary flow velocity from the parasternal short-axis
view. Right ventricular systolic pressure (RVSP) was deter-
mined by continuous-wave Doppler echocardiography and
was considered elevated when reaching values >30 mm Hg.
RA pressure was estimated according to caval dimensions.
Estimation of pulmonary vascular resistance (PVR) was
determined on the basis of the ratio of peak tricuspid
regurgitation velocity to RV outflow tract time-velocity integral
that was shown to be a good correlate of PVR despite
reflecting pulmonary systolic pressure and not the transpul-
monary pressure gradient.13 Pulmonary artery capacitance
was calculated as Doppler-derived stroke volume/pulmonary
artery pulse pressure.14 Tricuspid annulus systolic velocity (TV
Sa) and diastolic velocity (TV Ea) were measured at the lateral
corner of the tricuspid annulus on the transthoracic 4-
chamber view. TV E/Ea reflects increased RA pressure
12,15
and was taken as the parameter of RV diastolic function
Three-Dimensional Echocardiography
3DE was done using a dedicated wide-angle, broadband
matrix-array transducer to allow for full cover of the entire RV
by the pyramidal volume, with special attention to the outflow
tract and upper anterior wall. Before acquisitions, images were
optimized for the endocardial border visualization, modifying
overall gain and adjusting time gain and compression. Then they
were digitally stored for offline analysis by TomTec software
(TomTec Imaging Systems, Unterschleissheim, Germany).
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Three orthogonal planes and various landmarks were
selected to define the end-diastolic and end-systolic frames.
The program automatically supplies 4-chamber, sagittal, and
coronal RV views on the basis of the initial view adjustment.
RVEDV and RVESV were calculated from 3D echocardio-
graphic data sets. RVEF was determined as follows: RVEF =
[(RVEDVRVESV)/RVEDV]9100 (Figure 1). Total RVEF was
automatically generated by the software. Inflow, outflow, and
apex RVEFs were measured by subtracting the minimum
(end-systolic) volume from the maximum (end-diastolic)
volume of the respective compartment divided by the end-
diastolic volume. Volume changes during the cardiac cycle
were assessed.
Speckle-Tracking Echocardiography
The general principles that underlie 2D speckle-tracking
modalities have been previously described.15–21 Patients were
placed in the left lateral decubitus position and examined with
an active matrix single-crystal phased-array transducer (GE-
M5S). Grayscale recordings were optimized at a mean frame
rate of ≥50 frames/s. Apical 4-chamber views were used to
assess the RV inflow compartment, and special care was
taken to ensure a proper image of the entire RV by narrowing
the width of the 2D sector, or by placing the transducer in 1
intercostal space lower and side. To assess regional and
global longitudinal RV systolic function, we adopted a 6-
segment RV model (basal RV free wall, mid RV free wall, apical
RV wall, apical septum, mid septum, and basal septum). Peak
systolic strain was recorded for the 3 RV myocardial free wall
and septal segments, and the entire RV wall and RV free-wall
segments were selected for measurements (Figure 2). RV
outflow compartment was assessed by tracing along the right
ventricular outflow tract wall in parasternal short axis views as
previously described20 and displaying the corresponding
segmental and global strain curves. Time to peak negative
strain with respect to the onset of the Q-wave of the
superimposed ECG was measured for inflow and outflow
segments. The echocardiographic results were analyzed by an
echocardiologist (A.V.) blinded to the clinical data, using
dedicated software (EchoPAC BT12, 4D Auto LVQ; GE
Vingmed Ultrasound, Horten, Norway).
Table 1. Baseline Characteristics of Pulmonary Hypertension Patients and Normal Controls
PAH (n=25)
COPD (n=23) MR (n=25) Controls (n=30) P ValueSS (n=12) CHD (n=13)
Age, y 5311 5213 5514 5111 5415 ns
Sex, M/F 5/7 6/7 10/13 11/14 13/17 ns
BSA, m2 1.840.13 1.820.15 1.890.17 1.840.11 1.870.16 ns
BMI, kg/m2 234 225 234 225 233 ns
HR, beats/min 7410 7211 749 7311 658 ns
NYHA-FC III/IV 4 (33%) 3 (25%) 6 (26%) 8 (32%) — ns
SBP, mm Hg 11613 11914 12111 12016 11415 ns
DBP, mm Hg 679 6710 6910 657 638 ns
Mean RAP, mm Hg 15.34.9 14.25.1 13.23.8 11.44.4 — <0.05*
Systolic PAP, mm Hg 66.116.8 64.514.3 47.211.8 42.712.4 — <0.05†, <0.01‡
Diastolic PAP, mm Hg 25.911.9 25.310.1 24.27.8 22.76.4 — ns
Mean PAP, mm Hg 44.910.3 42.19.4 37.85.3 32.94.9 — <0.05*§
PCWP, mm Hg 8.73.6 8.93.9 7.43.1 22.63.8 — <0.001*
TPG, mm Hg 36.111.6 33.413.2 31.29.3 10.24.8 — <0.005*§
PAC, mL/mm Hg 0.80.2 1.10.3 1.70.8 2.80.7 — <0.001*§
PVR, WU 5.92.3 5.22.4 3.90.8 1.70.4 — <0.05†§, <0.005‡
CI, L/min per m2 2.30.5 2.40.4 2.60.5 3.40.5 — <0.05*
BMI indicates body mass index; BSA, body surface area; CHD, congenital heart disease; CI, cardiac index; COPD, chronic obstructive pulmonary disease; DBP, diastolic blood pressure; HR,
heart rate; MR, mitral regurgitation; ns, not statistically significant; NYHA-FC, New York Heart Association functional class; PAC, pulmonary artery capacitance; PAH, pulmonary arterial
hypertension; PAP, pulmonary artery pressure; PCWP, pulmonary capillary wedge pressure; PVR, pulmonary vascular resistance; RAP, right atrial pressure; SBP, systolic blood pressure; SS,
systemic sclerosis; TPG, transpulmonary pressure gradient; WU, Wood units.
*SS, CHD, and COPD vs MR.
†SS and CHD vs COPD.
‡SS and CHD vs MR.
§SS vs CHD.
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3D speckle-tracking analysis was performed after imaging
the RV chamber in apical views by using a 4V phased array
transducer with high volume rate (≥30 image frames/s) and
6-beat acquisition. 3D global longitudinal strain of whole RV
(17 segments) was calculated using the Echo PAC BT12
(Figure 2). 3D global longitudinal strain of RV free-wall only
(3D Global-FW RVLS) was calculated using Excel data.10 3D
global area strain (AS) was determined as the percentage
decrease in the size of endocardial surface area defined by
the vectors of longitudinal and circumferential deforma-
tions.11 3D global area strain of RV free-wall only (3D
Global-FW AS) was then calculated.
Cardiac Catheterization
PH was confirmed by cardiac catheterization and right-heart
hemodynamic measurements. These studies were performed
under fluoroscopic guidance via a femoral vein approach
within 3 days of echocardiography with a mean interval of
1.40.4 days. Measurements were obtained at end expira-
tion after zero-pressure calibration and included right atrial,
pulmonary arterial peak systolic and end-diastolic, and
pulmonary capillary wedge pressures. Mean pulmonary artery
pressure, PVR, transpulmonary pressure gradient (mean
pulmonary artery pressure minus mean wedge pressure),
and pulmonary artery capacitance (ratio of stroke volume over
pulmonary pulse pressure) were calculated. Cardiac output
was determined by thermodilution22 and indexed to body
surface area to obtain cardiac index.
Statistics
Categorical variables are presented as numbers and percent-
ages and continuous data are expressed as meanSD.
A B
C
Figure 1. Representative 3D RV volumes and ejection fraction in normal controls and PH patients. A, Three-dimensional RV ejection fraction
(3D-RVEF) in a normal subject. 3D-RVEF=59%. B, Decrease of 3D-RVEF in a patient with chronic PH. 3D-RVEF=35%. C, Regional three-dimensional
RV ejection fraction. RV components are illustrated in a three-dimensional reconstruction of the echocardiographic images seen in a front view. 1,
inlet; 2, apical trabecular; 3, outlet component. EDV indicates end-diastolic volume; EF, ejection fraction; ESV, end-systolic volume; P, pulmonary
outflow; PH, pulmonary hypertension; RV, right ventricular; RVEF, RV ejection fraction; SV, stroke volume; T, tricuspid inflow.
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Patients were divided into 5 groups (systemic sclerosis,
congenital heart disease, COPD, mitral regurgitation, and
controls). Echocardiographic parameters of RV function
(standard, STE, 3D) as well as cardiac catheterization
parameters were compared between groups using Student
unpaired t tests. Differences among 3 or more groups were
assessed using 1-way ANOVA. Differences were considered
statistically significant when the P value was <0.05. Cox
proportional hazards regression models were used to identify
clinical, echocardiographic, and invasive hemodynamic vari-
ables independently associated with all-cause mortality.
Candidate predictors were age, gender, New York Heart
Association functional class (I to IV), heart rate, invasive PVR,
invasive RA pressure, invasive mean pulmonary arterial
pressure, invasive pulmonary artery capacitance, and RV
function echocardiographic parameters. The shared frailty
model was used with multivariate survival data where the
unobserved frailty is shared among groups of individuals
(random effects model for survival data). Receiver operating
characteristic curves were used to determine diagnostic
accuracy of standard RV function indices, RV strain param-
eters, and 3D-RVEF for the detection of RV failure hemody-
namic signs (cardiac index <2 L/min per m2, RA pressure
>15) such as described in previous reports.23,24 To assess
the incremental value of 3DGFW-RVLS+3D-RVEF in predicting
precapillary PH (pulmonary capillary wedge pressure
<15 mm Hg) over traditional echocardiographic parameters,
v2 increase of the multivariate model in logistic regression
analysis was determined. Global v2 value was measured in 3
steps. Step 1 included RVSP +MV-E/Ea (ratio of early
diastolic mitral inflow velocity to early diastolic mitral annular
velocity with values <12 suggesting normal LV diastolic
A B
C D
Figure 2. Representative 2D and 3D RV strain images in normal controls and PH patients. A, Speckle-tracking apical view showing global and
regional RV longitudinal strain in a normal subject. Global RV longitudinal strain (G-RVLS)=28%. B, Speckle-tracking apical view showing global
and regional free-wall RV longitudinal strain in a normal subject. Free wall (FW) is labeled by asterisks. Global free-wall RV longitudinal strain
(GFW-RVLS)=36%. C, Decrease of GFW-RVLS in a patient with chronic PH. GFW-RVLS=13%. D, 3D RV speckle-tracking multiplane view in a
normal subject. 3D global longitudinal strain (3D G-RVLS) was 26%. 3D global longitudinal strain of RV free-wall (3D GFW-RVLS) was then
calculated excluding septal segments. FW is labeled by asterisks. AVC indicates aortic valve closure; ED, end-diastolic; ES, end-systolic; PH,
pulmonary hypertension; RV, right ventricular.
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function). Step 2 included RVSP+MV-E/Ea+3DGFW-RVLS.
Step 3 included RVSP+MV-E/Ea+3DGFW-RVLS+3D-RVEF.
Intra- and interobserver variability of strain and volumes
measurements was evaluated in 10 randomly selected
patients. To analyze intraobserver variability, measurements
of parameters were made at multiple sites in different
patients on 2 different occasions. For interobserver variabil-
ity, a second investigator randomly made measurements at
the above different sites without knowledge of other
echocardiographic parameters. Variability was assessed
using intraclass correlation coefficients for total agreement,
with good agreement defined as >0.80. Mean values and SDs
between the measurements were determined, and total
agreement among the observation was obtained using
intraclass correlation analysis.
Results
Seventy-three patients with PH were included in the study.
Ninety-four patients were initially evaluated. 2D and 3D
speckle-tracking measurement from all segments and 3D RV
volumetric analysis were not feasible in 8, 16, and 17
patients, respectively. Nine of the 17 patients excluded
because 3D volume rendering was not allowed were patients
with COPD. 3D feasibility was 82%, 2D strain feasibility was
92%, and 3D strain feasibility was 83%. Tricuspid regurgita-
tion to estimate right-sided pressure was found in 73/94
patients (78%).
The baseline characteristics of PH patients and controls
are given in Table 1. Echocardiographic parameters in PH
patients and controls are presented in Table 2. TAPSE and
FAC were lower and myocardial performance index was higher
in PH patients. TV E/E’ was increased and global and regional
3D-RVEF was reduced compared to controls. MV E/E’ was
significantly increased in MR patients compared to controls.
Global and global-FW RVLS as well as right ventricular
outflow tract longitudinal strain were significantly lower in all
groups of patients than in controls. LVEF was unchanged,
whereas LVED was larger in MR patients compared to
controls. Reproducibility of 3D-STE analyses is summarized
in Table 3.
The total duration of 3D-STE data analysis averaged
8.31.7 minutes, which was 33% less than the time used
for 2D analyses (12.32.7 minutes, P<0.005). Both image
acquisition time (2.40.6 minutes versus 3.71.2 minutes,
P<0.005) and offline analysis time (5.91.6 minutes versus
8.61.9 minutes, P<0.001) were significantly faster for 3D-
STE compared with 2D-STE. Analysis time included calculation
of areas and volumes and 2D-3D wall strains in different views
from a single vendor-specific algorithm. Global LS measured
by 2D-STE and 3D-STE showed a significant correlation
(r=0.79, P<0.005). The correlation coefficient for segmental
strain measured with 2D-STE and 3D-STE was 0.56 (P<0.05).
Both 3DGFW-RVLS and 3D-RVEF (Table 4) correlated
similarly (P<0.05) with mean pulmonary artery pressure and
PVR. A positive correlation was shown between 3DGFW-RVLS
and RA pressure (P<0.01), and transpulmonary gradient
(P=0.03). There was a negative correlation between 3DGFW-
RVLS and pulmonary artery capacitance (P=0.02), and cardiac
index (P<0.01). Tricuspid valve annular systolic velocity and
RVFAC had a significant, but weaker, correlation with cardiac
index (P<0.05) and no association with transpulmonary
gradient or pulmonary vascular resistance. No correlation
was obtained between RV outflow volume-strain parameters
and right heart pressures.
Figure 3 analyzes RV global-free-wall longitudinal strain
(GFW-RVLS), basal-free-wall longitudinal strain (BFW-RVLS),
mid-free-wall longitudinal strain (MFW-RVLS), and apical-free-
wall longitudinal strain (AFW-RVLS) in normal subjects and
patients with PH (PAH, COPD, MR). Patients with precapillary
PH (PAH, COPD) had lower global and regional peak systolic
RV free-wall strain compared to patients with postcapillary PH
(MR).
To assess the incremental value of 3DGFW-RVLS+3D-RVEF
in predicting precapillary PH (pulmonary capillary wedge
pressure <15 mm Hg) over traditional echocardiographic
parameters, global v2 value was measured in 3 steps, as
described in the Methods section. A significant improvement
in global v2 value was noted (Figure 4) with strain and 3D
parameters over traditional indices for the prediction of
precapillary PH. The v2 values improved from 76.1 to 81.8
(P<0.005) and from 81.8 to 90.9 (P=0.004).
The diagnostic accuracy of RV strain and 3D-RVEF for
detecting hemodynamic signs of RV failure (a composite of
cardiac index <2 L/min per m2 and RA pressure >15) was
shown by receiver-operating characteristic curves (Table 5).
3D-RVEF (0.89) had the highest area under the curve (P<0.05
compared to 3D-RVEF-inflow, P<0.001 compared to TAPSE),
followed by 3D-GFW-RVAS (0.88), 3D-GFW-RVLS (0.88), GFW-
RVLS (0.88), BFW-RVLS (0.85), AFW-RVLS (0.85), 3D-RVEF-
apex (0.82), 3D-RVEF-inflow (0.81), 3D-RVEF-outflow (0.72),
right ventricular outflow tract LS (0.69), and MFW RVLS (0.67).
Overall all-cause mortality at 2 years was 17.8% (13
patients). Proportional hazards modeling showed that death
was associated with New York Heart Association functional
class (P=0.02), age (P=0.04), male gender (P<0.05), invasive
right atrial pressure (P<0.001), invasive pulmonary artery
capacitance (P=0.013), invasive PVR (P=0.02), tricuspid valve
annular systolic velocity (P=0.03), TAPSE (P=0.03), 3D-GFW-
RVLS (P=0.002), and 3D-RVEF (P<0.001). In multivariate
analysis, after adjusting for other predictors of mortality
(significant predictors in univariate analysis), invasive RA
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pressure (hazard ratio 6.2, P=0.001, 95% confidence interval
3.15 to 10.27), 3D-GFW-RVLS (hazard ratio 4.6, P=0.004, 95%
CI 2.79 to 8.38), and 3D-RVEF (hazard ratio 5.3, P=0.002, 95%
CI 2.85 to 9.89) were independent predictors of mortality.
Discussion
The results of the present study are as follows: (1) In chronic
PH setting, 3DE and STE parameters can detect global and
Table 2. Echocardiographic Parameters in PH Patients and Controls
PAH (n=25)
COPD (n=23) MR (n=25) Controls (n=30) P ValueSS (n=12) CHD (n=13)
RV/LV 1.250.25 1.210.27 1.020.29 0.960.21 0.680.14 <0.01*
LVEDV, mL 12217 11819 11215 16127 11916 <0.05†
LVEF, % 58.67.7 59.97.4 60.36.8 62.47.3 61.36.2 ns
MV E/Ea 8.72.6 8.92.5 9.32.8 17.76.8 5.43.6 <0.01†
RVFAC, % 3210 3213 359 3610 4914 <0.05*
TAPSE, mm 145 156 166 174 235 <0.05*
RVMPI 0.550.11 0.580.12 0.410.12 0.390.10 0.240.06 <0.05*
TV Sa, cm/s 7.23.3 7.13.1 8.72.7 9.63.2 12.92.4 <0.05*
TV Ea, cm/s 8.13.4 8.53.1 8.62.9 9.23.1 15.63.5 <0.05*
TV E/Ea 15.11.7 14.31.9 12.31.4 10.91.1 8.30.9 <0.05*
RVSP, mm Hg 7912 7410 4913 4514 223 <0.01*
PVR, WU 6.52.5 6.12.2 4.21.3 2.10.8 1.30.4 <0.05*
PAC, mL/mm Hg 0.70.2 0.90.2 1.50.9 1.80.7 3.21.9 <0.01*
TR, grade 0 to 3 1.80.5 1.90.4 1.20.3 1.70.6 0.30.2 <0.05*
PAT, ms 63.112.1 68.311.4 85.812.7 92.26.4 129.824.3 <0.05*
3D-RVEDV, mL 19146 19954 14331 15228 7817 <0.005*
3D-RVESV, mL 12327 11629 9423 10222 349 <0.005*
3D-RVEF, % 35.57.6 36.48.2 38.17.6 40.78.1 53.67.2 <0.0001‡, <0.001§||, <0.05†
3D-RVEF-inflow, % 33.17.4 32.87.9 34.67.3 39.76.7 54.17.6 <0.001‡, <0.005§||, <0.05†
3D-RVEF-outflow, % 45.29.8 44.98.7 47.49.2 46.36.8 55.78.5 <0.05*
3D-RVEF-apex, % 26.34.4 27.84.6 30.15.2 29.63.9 42.48.1 <0.01†‡§, <0.05||
RVOT LS, % 7.64.8 7.34.4 8.12.6 7.93.9 9.15.1 <0.05*
Global RVLS, % 19.14.6 19.64.1 20.34.9 21.74.1 24.13.6 <0.05*
Apical-FW RVLS, % 10.94.3 11.74.1 14.94.8 14.65.1 21.74.6 <0.0001‡,<0.0005§, <0.01†||
Mid-FW RVLS, % 18.26.4 18.96.7 23.46.9 22.57.6 25.34.3 <0.05‡
Basal-FW RVLS, % 11.87.8 12.87.4 16.38.3 20.97.8 26.84.2 <0.0005‡§,<0.001||, <0.05†
Global-FW RVLS, % 17.74.9 18.65.1 19.24.7 20.84.4 25.95.7 <0.0001‡§, <0.001||, <0.01†
3D Global RVLS, % 17.14.3 17.44.9 18.94.8 20.34.1 22.43.5 <0.05*
3D Global-FW RVLS, % 16.25.1 17.15.2 18.44.4 19.73.9 23.85.8 <0.0001‡§, <0.001||, <0.01†
3D Global-FW AS, % 22.45.3 23.95.1 24.74.8 25.94.7 34.65.8 <0.0001‡§, <0.001||, <0.01†
3D indicates three-dimensional; AS, area strain; CHD, congenital heart disease; COPD, chronic obstructive pulmonary disease; E, inflow early diastolic velocity; Ea, annular early diastolic
velocity; FW, free wall; LV, left ventricular; LVEDV, left ventricular end-diastolic volume; LVEF, left ventricular ejection fraction; MR, mitral regurgitation; MV, mitral valve; PAC, pulmonary
artery capacitance; PAH, pulmonary arterial hypertension; PAT, pulmonary acceleration time; PH, pulmonary hypertension; PVR, pulmonary vascular resistance; RV, right ventricular; RV/LV,
ratio of RV to LV end-diastolic diameters (4-chamber view); RVEDV, right ventricular end-diastolic volume; RVEF, right ventricular ejection fraction; RVESV, right ventricular end-systolic
volume; RVFAC, right ventricular fractional area change; RVLS, right ventricular longitudinal strain; RVMPI, right ventricular myocardial performance index; RVOT LS, right ventricular
outflow tract longitudinal strain; RVSP, right ventricular systolic pressure; Sa, annular systolic velocity; SS, systemic sclerosis; TAPSE, tricuspid annular plane systolic excursion; TR,
tricuspid regurgitation; TV, tricuspid valve; WU, Wood units.
*All vs controls.
†MR vs controls.
‡SS vs controls.
§CHD vs controls.
||COPD vs controls.
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regional RV dysfunction; (2) different forms of PH (precapil-
lary, postcapillary) can differently affect RV deformation; and
(3) 3DE and STE parameters are more powerful predictors of
hemodynamic signs of RV failure compared to conventional
RV indices.
Previous Studies
Despite the prominent role of RV in PH prognosis, little is
known about segmental patterns of RV function, and literature
results have been conflicting. Previous studies using tissue
Doppler imaging, STE, and 3DE6–9,21,25–29 reported various
patterns of RV remodeling in patients with chronic PH. A
reduced apical RV longitudinal strain allowed feasible and
reliable estimation of PH and appeared helpful to distinguish
between pre- and postcapillary PH.26 An apical dysfunction
was also emphasized by magnetic resonance imaging (MRI)
studies.27 Other authors showed moderate or severe RV
dysfunction with decrease of strain of the basal segment of
the RV free wall in patients with COPD6 and PH of mixed
etiologies.21,25 There was improvement in regional 2D defor-
mation parameters with long-term oral vasodilator therapy.21
Low values of RV lateral free-wall 2D strain were found in
patients with arterial and thromboembolic PH.8 The impor-
tance of RV outflow tract function has been stressed by STE
and MRI studies20,28 showing increase of infundibular wall
stress and decrease of fractional wall thickening in patients
with PH of different etiologies. Serial quantitative assessment
of RV function by strain29 independently predicted clinical
deterioration and mortality in patients with PAH after the
institution of medical therapy.
The use of 3DE in the assessment of chronic PH4,30
showed a different extent of contribution to the overall
systolic function for the inflow, apical, and outflow tract
Table 3. Reproducibility of 3D and 2D-3D-STE Echocardiographic Analyses in a Subset of 10 Randomly Selected Patients With PH
Variable
Intraobserver Interobserver
Mean DifferenceSD ICC CV (%) Mean DifferenceSD ICC CV (%)
3D-RVEDV, mL 4.92.9 0.93 1.32 5.32.8 0.89 1.82
3D-RVESV, mL 5.73.6 0.87 1.95 5.93.9 0.82 2.41
3D-RVEF, % 5.93.8% 0.89 2.94 6.44.1 0.86 2.98
Global RVLS, % 6.02.9% 0.83 2.42 6.72.8% 0.77 3.81
Global-FW RVLS, % 5.43.1% 0.87 2.56 6.53.5% 0.83 2.95
Basal-FW RVLS, % 5.52.6% 0.85 2.92 5.52.7% 0.79 2.25
Mid-FW RVLS, % 6.12.6% 0.83 3.26 6.52.5% 0.78 3.47
Apical-FW RVLS, % 5.33.7% 0.86 2.34 5.93.5% 0.83 2.17
3D Global-FW RVLS, % 5.12.4% 0.92 1.87 6.03.1% 0.85 2.38
3D Global-FW AS, % 5.22.2% 0.91 2.12 5.92.5% 0.85 2.59
2D indicates two-dimensional; 3D, three-dimensional; AS, area strain; CV, coefficient of variation (calculated as the difference of repeated measurements expressed as a percentage of the
mean); FW, free wall; ICC, intraclass correlation coefficient for absolute agreement; PH, pulmonary hypertension; RVEDV, right ventricular end-diastolic volume; RVEF, right ventricular
ejection fraction; RVESV, right ventricular end-systolic volume; RVLS, right ventricular longitudinal strain; STE, speckle-tracking echocardiography.
Table 4. Correlation of RV Function Echocardiographic Parameters With Invasive Hemodynamic Variables
Right Heart Catheterization Data
RVFAC TV-Sa 3D-GFW-RVLS 3D-RVEF
r Value P Value r Value P Value r Value P Value r Value P Value
Mean PAP, mm Hg 0.24 0.06 0.31 <0.05 0.47 <0.05 0.51 <0.05
PVR, WU 0.19 0.08 0.22 0.06 0.51 <0.05 0.53 <0.05
TPG, mm Hg 0.23 0.07 0.24 0.06 0.50 0.03 0.52 0.04
PAC, mL/mm Hg 0.22 0.07 0.29 <0.05 0.54 0.02 0.55 0.02
Mean RAP, mm Hg 0.32 <0.05 0.36 <0.05 0.63 <0.01 0.64 <0.01
CI, L/min per m2 0.38 <0.05 0.42 <0.05 0.61 <0.01 0.60 <0.01
CI indicates cardiac index; 3D, three-dimensional; GFW-RVLS, global free-wall right ventricular longitudinal strain; PAC, pulmonary artery capacitance; PAP, pulmonary artery pressure; PVR,
pulmonary vascular resistance; RAP, right atrial pressure; RVEF, right ventricular ejection fraction; RVFAC, right ventricular fractional area change; TPG, transpulmonary pressure gradient;
TV-Sa, tricuspid valve annular systolic velocity; WU, Wood units.
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compartments. Other studies described a significant associ-
ation of 3D longitudinal strain10 and area strain11 with RVEF
and a prognostic value independent of other variables.
Present Study
Our report differs from previous literature in some respects.
First, we analyzed comparatively the diagnostic accuracy of
3DE and 2D-3D-strain indices showing a better association
with hemodynamic variables reflecting right heart failure than
standard echo indices. To the best of our knowledge, this is
the first study assessing the relation between these echocar-
diographic indices and the hemodynamic parameters indica-
tive of RV failure. Second, RV strain impairment was more
marked in patients with precapillary PH and less pronounced
in patients with postcapillary PH and LV diastolic dysfunction
and, even if overlap between groups limits its clinical utility,
this finding showed an additional value compared to standard
echo parameters, and this is of interest since current
guidelines point out the importance of early diagnosis of
precapillary PH and differentiation from other PH entities.1,2,26
Third, the apex involvement was a constant feature of RV
dysfunction in chronic PH. This pattern is different from that
seen in the acute pulmonary embolism setting as reported by
ourselves31 and others,32 where reduced RV free wall
contraction is found with preserved apical wall motion on
2DE. No bulging of the mid–RV free wall relative to the apex
and base occurs in chronic PH since RV hypertrophy may limit
shape changes and tethering effects.
The global and regional RV deformation patterns that we
found in chronic PH can be explained by the complex and
different pathophysiologic mechanisms in PH groups.33–38 To
group PH entities according to their pathophysiological–
clinical mechanisms and response to medical therapy
certainly helps clinical practice, although it is an oversimpli-
fication since differences exist within various subgroups.
Systemic sclerosis–associated pulmonary artery hypertension
(PAH-SS) has a poorer prognosis33 than that of other types of
PH,34 with a median survival of 3 years. This could be
explained by intrinsic myocardial involvement of the disease
related to abnormal collagen deposition, or an increased
vulnerability to ischemia due to coronary vasculopathy in
Figure 3. Bar graph depicting global and segmental strain changes in RV free wall in PH patients. RV
global-free-wall longitudinal strain (GFW-RVLS, top left) with higher decrease of RV global strain in
precapillary PH (pre-c) compared to postcapillary PH (post-c). Apical-free-wall longitudinal strain (AFW-
RVLS, top right), mid-free-wall longitudinal strain (MFW-RVLS, bottom left), and basal-free-wall longitudinal
strain (BFW-RVLS, bottom right) in normal subjects and patients with PH and RV segmental involvement.
*SS vs C: P<0.0001; CHD vs C: P<0.0001; COPD vs C: P<0.001; MR vs C: P<0.01. †SS vs C: P<0.0001;
CHD vs C: P<0.0005; COPD vs C: P<0.01; MR vs C: P<0.01. ‡SS vs C: P<0.001; CHD vs C: P<0.001; COPD
vs C: not significative; MR vs C: not significative. §SS vs C: P<0.0005; CHD vs C: P<0.0005; COPD vs C:
P<0.001; MR vs C: P<0.05. C indicates controls; CHD, congenital heart disease; COPD, chronic obstructive
pulmonary disease; MR, mitral regurgitation; PH, pulmonary hypertension; RV, right ventricular; SS,
systemic sclerosis.
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addition to enhanced pulmonary vascular resistive and/or
pulsatile loading. Patients with systemic sclerosis–associated
pulmonary artery hypertension had higher values of pulmo-
nary artery pressure and PVR, lower values of pulmonary
artery capacitance, a more diffuse impairment in RV strain,
and lower strain values compared to PAH-congenital heart
disease, COPD, and MR patients. Actually, disorders associ-
ated with chronic lung disease or hypoxia are generally
characterized by moderate PH, and RV dysfunction is
characterized by hypertrophy with preserved cardiac func-
tion.35 Nevertheless, RV failure can occur during disease
exacerbations or when multiple comorbidities are present. PH
is only mildly elevated also in chronic MR; it develops after the
increased left atrial pressure (postcapillary), and the right
ventricle is less dilated compared to PAH.36 However, the
presence of PH secondary to MR is a determinant of long-
term survival, and RVEF has been shown to be an independent
predictor of survival in patients with heart failure. The findings
of our study are in line with previous reports4,28 that
described different global and regional RV changes in patients
with different RV pressure overload.
In our population, both 2D-STE and 3D-STE were shown to
be more sensitive to detect subtle myocardial damage
compared to conventional indices of RV function. 3D area
strain is a combination of longitudinal and circumferential
function and has already been validated as a useful
measurement of LV function.39 Since it has integrated
2-directional components of myocardial deformation (longitu-
dinal and circumferential), area strain might decrease the
tracking error and emphasize synergistically the magnitude of
deformation. Thus it is reasonable to expect that deteriorated
ventricular function can be detected at an earlier stage by
using 3D speckle-tracking analysis in comparison with
1-directional strain.40 However, the superiority of 3D-STE
over 2D-STE for the evaluation of all 3 components of LV
deformation (longitudinal, circumferential, and radial) has
been questioned.41 The 3D mode avoids foreshortening of
apical views, consumes less time in data acquisition, helps to
solve the problem of out-of-plane motion present in the 2D
modality tracking motion of speckles in all 3 dimensions, but
this advantage is achieved at the expense of lower volume
rate. Similar considerations can be made for the right
ventricle; however, our results showed that the new 3D-STE
measurements had strong associations with hemodynamic
parameters indicative of RV failure, albeit we did not find any
superior clinical advantage over 2D-STE except for a more
rapid acquisition and offline-analysis time.
Our finding is partially coincident with previous
research3,4,30,37 suggesting that the change of volume and
systolic function was at least in part related to high RV
afterload caused by increased pulmonary artery pressure and
PVR and existed in all of the 3 RV compartments. Further-
more, we showed that decrease in RV strain can be localized
at the regional level (basal, apical) or widespread in the RV
free wall. The decrease of EF and strain in the body and inflow
compartment compared to controls were more significant
than those in the outflow chamber. The early impairment of
RV inflow systolic function could be explained by the
predominant role of inflow contraction in RV global perfor-
mance, and this is in keeping with the phylogenetic research
that showed37 that the RV sinus (inflow and body) compart-
ments developed a million years after the outflow compart-
ment, probably as an adaptation of the cardiovascular system
to breathing air.
The moderate correlation we obtained between PVR and
RVEF is in keeping with previous studies42 that showed that in
chronic PH, RV function does not fully adapt to changes in
vascular properties and can decline independent of PVR, and
RV contractility may increase during early PH and then
decrease in a more advanced stage when pulmonary artery
pressures fail to increase further. Other factors may play an
important role in the changes in RVEF over time, including
older age, genetic differences in RV adaptation to pressure
overload, and ventricular wall tension.42 Moreover, correla-
tions between RV function echocardiographic parameters and
mean pulmonary artery pressure obtained via catheterization
may be stronger in pulmonary hypertensive patients solely
with right-sided disease and weaker in mixed populations
including patients with LV overload and/or dysfunction.7
Figure 4. Incremental value of three-dimensional
RV ejection fraction (3D-RVEF) and global-free-wall
RV longitudinal strain (3DGFW-RVLS) over standard
echocardiographic variables in predicting precapil-
lary PH (PCWP <15 mm Hg). Step 1 included RVSP
(right ventricular systolic pressure)+MV-E/Ea (ratio
of early diastolic mitral inflow velocity to early
diastolic mitral annular velocity: values <12 suggest
normal LV diastolic function). Step 2 included
RVSP+MV-E/Ea+3DGFW-RVLS. Step 3 included
RVSP+MV-E/Ea+3DGFW-RVLS+3D-RVEF. *Step 1
vs step 2: v2 values 76.1 vs 81.8, P<0.005; †Step 2
vs step 3: v2 values 81.8 vs 90.9, P=0.004. LV
indicates left ventricular; MV, mitral valve; PCWP,
pulmonary capillary wedge pressure; PH, pulmonary
hypertension; RV, right ventricular.
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We have already reported18,31 that the newer technol-
ogies appear to be superior to conventional technologies,
including RVFAC, TAPSE, and myocardial performance index.
In our cohort of patients with chronic PH, the assessment
of 3D RVEF and strain gave us valuable information on
global and regional RV function with better diagnostic
accuracy in predicting RV failure hemodynamics compared
to the other methods. Also, in our study we have found
some common strong prognostic factors with chronic PH,
such as age, New York Heart Association functional class,
invasive right atrial pressure, pulmonary artery capacitance,
pulmonary vascular resistance, TAPSE, 3D-GFW-RVLS, and
3D-RVEF. The results concerning the prognostic value of
pulmonary artery capacitance provide further evidence that
pulsatile components (pulmonary artery capacitance) of RV
afterload give additional information compared to the static
part (PVR) of RV afterload.14,43 STE and 3D echocardio-
graphic parameters tended to be associated with adverse
events in univariate analysis and were independently
associated with adverse events in multivariate analysis,
and these data are in keeping with recent reports11
showing that reduced RV strain was associated with poor
outcome in PH patients.
Clinical Implications
We have shown that in chronic PH patients, 3D RV volumes
and 2D-3D strains are better predictors of the hemodynamic
indices of RV failure compared to conventional RV parameters
as well as better predictors of mortality. Both RV global
function parameters and regional strain indices of the inflow
region and apex appeared to detect early signs of ventricular
failure. Their use could improve the evaluation of subtle RV
changes when TAPSE, tricuspid valve annular systolic velocity,
and FAC are not conclusive or in the first stages of PH when
TAPSE is known to be still normal. The described cutoff values
for global and regional RV echo parameters (3D-RVEF 39%, 3D
global-FW RVLS 17%, basal-FW RVLS 19%, apical-FW RVLS
16%) may allow PH patients to be followed serially and to
assess the response to medical therapy.
Limitations
Our study did have some limitations. First, RV 2D-strain
analysis software was used assuming that the LV algorithm
could be transferred to the right ventricle. However, it has
been applied to the RV in several clinical studies,8,16,17 albeit
Table 5. Results of Receiver-Operating Characteristic Curves Comparing Different Echocardiographic Parameters in all PH Cohorts
for Their Accuracy to Predict Hemodynamic Parameters of RV Failure
Parameter AUC 95% CI P Value Cutoff Sensitivity Specificity
2D-TVI
RVFAC 0.62 0.47 to 0.86 0.08 38% 72 60
TV-Sa 0.66 0.52 to 0.89 0.06 9.2 cm/s 75 65
TAPSE 0.67 0.53 to 0.88 0.05 16 mm 76 64
Strain
RVOT LS 0.69 0.51 to 0.82 0.04 7.4% 79 64
Mid-FW RVLS 0.67 0.63 to 0.90 0.06 18% 76 65
Apical-FW RVLS 0.85 0.69 to 0.97 0.03 16% 86 76
Basal-FW RVLS 0.85 0.72 to 0.96 0.02 19% 86 78
Global-FW RVLS 0.88 0.69 to 0.98 0.01 18% 89 74
3D Global-FW RVLS 0.88* 0.71 to 0.97 0.01 17% 89 77
3D Global-FW AS 0.88* 0.72 to 0.99 0.01 27% 89 78
3D volumes
3D-RVEF-outflow 0.72 0.58 to 0.87 0.05 42% 77 64
3D-RVEF-apex 0.81 0.61 to 0.91 0.04 28% 81 73
3D-RVEF-inflow 0.82 0.76 to 0.98 0.03 36% 82 75
3D-RVEF 0.89† 0.68 to 0.99 <0.01 39% 90 83
2D indicates two-dimensional; 3D, three-dimensional; AS, area strain; AUC, area under the curve; FW RVLS, free-wall right ventricular longitudinal strain; PH, pulmonary hypertension; RVEF,
right ventricular ejection fraction; RVFAC, right ventricular fractional area change; RVOT LS, right ventricular outflow tract longitudinal strain; TAPSE, tricuspid annular plane systolic
excursion; TVI, tissue velocity imaging; TV-Sa, tricuspid valve annular systolic velocity.
*P<0.05 compared to Basal-FW RVLS, P<0.005 compared to TAPSE.
†P<0.05 compared to 3D-RVEF-inflow, P<0.001 compared to TAPSE.
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reproducibility should undergo further validation. Second, STE
is dependent both on frame rate and image resolution. We
used frame rates in the range of 60 to 100 Hz, which is a
lower value than a frame rate suitable for Doppler strain.
However, STE may overcome some tissue Doppler limitations
because it is less affected by passive translational motion or
tethering in the assessment of myocardial thickening. Third,
although the problem of variations between the different
systems and vendors was recently stressed in terms of
speckle-tracking analysis,44 a comparison of data obtained
using the various systems would be appropriate, and this
problem will require collaboration between manufacturers.
Fourth, 3D-STE software has been designed for LV assess-
ment, and development of a specific RV software would be
desirable. Fifth, cardiac catheterization and echocardiographic
measurements were not obtained simultaneously, and poten-
tially measurements in different hemodynamic states might
have occurred. However, the mean time between echo and
catheterization was 1.4 days; thus, it is very unlikely that
conclusions were affected by this delay. An additional
limitation was that cardiac output was measured invasively
using thermodilution, and this method may lack accuracy in
patients with PH due to congenital intracardiac shunts or in
patients with significant tricuspid regurgitation. However,
tricuspid regurgitation was mild in the majority of our
patients, and also it has been shown that this method is
equally as accurate as other methods of measuring cardiac
output even in the presence of tricuspid regurgitation.22
Another limitation was that the accuracy of 3D volume and EF
is less reliable in significantly dilated and dysfunctional
ventricles because limited data are available in the litera-
ture.3,4 The 3D RV endocardial border identification may be
challenging as echo dropouts frequently occur, especially of the
anterior wall and outflow tract, and is even more challenging in
patients with dilated right ventricles, because the endocardial
border may be blurred due to the increased distance from the
transducer to the RV wall. The last limitation was the lack of
comparison with cardiac MRI. Previous studies showed a good
correlation between 3DE and MRI volumes in patients with PH3
but future studies correlating RV 3D-MRI tagging with 3D-STE
would be desirable.
Conclusions
In PH patients, the quantitative assessment of global and
regional RV function by 3D and STE provided us useful
hemodynamic and prognostic informations. The future soft-
ware improvements, the improving tracking ability of the STE
and 3D systems, and availability of a greater number of
patients with a longer follow-up will refine the evaluation of RV
dysfunction in chronic PH.
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